Drug Trial Radar · NCT00866944
Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
Last checked: Nov 19, 2026Latest source record: Nov 11, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Mar 2009
Primary completion
Jul 2011
Study completion Nov 2011
Sponsor
- Lead sponsor
- Amgen Research (Munich) GmbHAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 23, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effect of adecatumumab alone or following FOLFOX in patients with R0 resected liver metastases from CRC (colorectal carcinoma) and to compare the effect to FOLFOX alone.
Conditions
- Liver Metastases
- Colorectal Cancer
Interventions
AdecatumumabDrug
Adecatumumab,6-9mg/kg, every 14 days, 24 cycles
Adecatumumab and FOLFOXDrug
FOLFOX 4, every 14 days, 12 cycles followed by Adecatumumab, 6-9mg/kg, every 14 days, 12 cycles
FOLFOX 4Drug
FOLFOX 4, every 14 days, 12 cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease free survival rate (DFS)Time frame: 1 year
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Centre Paul Strauss
Strasbourg, France
Zentralklinikum Augsburg
Augsburg, Germany
Klinikum am Bruderwald, Sozialstiftung Bamberg
Bamberg, Germany
Charité Campus Virchow Klinikum
Berlin, Germany
Klinikum der Heinrich-Heine Universität
Düsseldorf, Germany
J.W. Goethe-Universität
Frankfurt, Germany
Martin-Luther Universität
Halle, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Klinikum Magdeburg gGmbH
Magdeburg, Germany
Klinikum der Johannes-Gutenberg Universität
Mainz, Germany
Klinikum Mannheim GmbH Universitätsklinikum
Mannheim, Germany
Universitätsklinikum der LMU Grosshadern
München, Germany
Städtisches Klinikum Neuperlach
München, Germany
Klinikum Oldenburg gGmbH
Oldenburg, Germany
Klinikum der Universität Regensburg
Regensburg, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.